glp 1 and 2 GLP-1-based therapies for type diabetes: from single, dual triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 Drug Savings: A Complete

Key findings: Those Who Stayed on the Maximum Tolerated Dose After 60 weeks of weight loss on tirzepatide, people who stayed on the same dose during a maintenance stage (52 weeks) kept off all the weight (about 50 pounds)

[DOI] [PMC free article] [PubMed] [Google Scholar] 48.Bluher M, Rosenstock J, Hoefler J, Manuel R, Hennige AM

All medications, including GLP-based therapies, are prescribed only when medically appropriate following evaluation by a licensed physician

Safe until kidneys cant clear it

However, much like MyFitnessPal, user error is a huge thing to consider

whether GLP1 is derived from the periphery or CNS, both the periphery & CNS, or when using a specific designer longacting GLP1 receptor agonist)